ACIP Recommends ‘Breakthrough’ Antibody Immunity Against RSV For Infants

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommended administration of a first-of-its-kind antibody immunization for infants that protects against respiratory syncytial virus (RSV), paving the way for cost-free coverage of the product despite its high price. Sarah Long, a professor of pediatrics at Drexel University College of Medicine and the chair of the ACIP working group for maternal and pediatric RSV vaccines, said she was “extraordinarily disappointed” with the manufacturers’ choice to price...